Propanc Biopharma, Inc. appointed Dr. Ralf Brandt to its Scientific Advisory Board. Dr. Brandt previously served as an Advisory Board member to Propanc over a seven-year period between 2011 and 2018. He will provide significant translational research expertise and clinical support advisory support services to the company’s drug development pipeline. He currently serves as President of Discovery and Early Development of Cancer Genetics.